Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477669 · ClinicalTrials.gov registry record · NA
Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants
A NA study, sponsored by University of Nebraska.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03477669 is a NA study that was terminated before completion, run by University of Nebraska. The registered enrollment target is 1 participants.
The verdict
NCT03477669, a NA study, was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The objective of this study is to determine the efficacy of a product combining the probiotic Lactobacillus GG and chamomile in treating infantile colic in exclusively breast fed infants. The study will be performed as a 4 week, placebo controlled, pilot trial with a one week run in period. Thirty subjects will be randomly assigned to each group for a total enrollment of 60 infants.
Interventions
- DIETARY_SUPPLEMENT chamomile/probiotic arm
- DIETARY_SUPPLEMENT Placebo of chamomile/probiotic arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-05-18 |
| Est. Completion | 2019-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03477669
The ClinicalTrials.gov registry entry for NCT03477669 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which chamomile/probiotic arm is the first listed.
NCT03477669 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03477669 about?
NCT03477669 is a clinical study titled "Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants". The objective of this study is to determine the efficacy of a product combining the probiotic Lactobacillus GG and chamomile in treating infantile colic in exclusively breast fed infants. The study will be performed as a 4 week, placebo controlled, pilot trial with a one week run in period. Thirty s...
What is the current status of trial NCT03477669?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2018-05-18. Estimated completion is 2019-02-25.
What interventions are being tested in trial NCT03477669?
The interventions under investigation include: chamomile/probiotic arm (DIETARY_SUPPLEMENT), Placebo of chamomile/probiotic arm (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03477669?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.